|
1
|
Fröhlich GM, Meier P, White SK, Yellon DM
and Hausenloy DJ: Myocardial reperfusion injury: Looking beyond
primary PCI. Eur Heart J. 34:1714–1722. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roger VL, Go AS, Lloyd-Jones DM, Adams RJ,
Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, et
al: Heart disease and stroke statistics-2011 update: A report from
the American heart association. Circulation. 123:e18–e209. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
GBD 2013 Mortality and Causes of Death
Collaborators: Global, regional, and national age-sex specific
all-cause and cause-specific mortality for 240 causes of death,
1990–2013: A systematic analysis for the global burden of disease
study 2013. Lancet. 385:117–171. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu HJ, Wang DG, Yan J and Xu J:
Up-regulation of microRNA-135a protects against myocardial
ischemia/reperfusion injury by decreasing TXNIP expression in
diabetic mice. Am J Transl Res. 7:2661–2671. 2015.PubMed/NCBI
|
|
5
|
Liu NB, Wu M, Chen C, Fujino M, Huang JS,
Zhu P and Li XK: Novel molecular targets participating in
myocardial ischemia-reperfusion injury and cardioprotection.
Cardiol Res Pract. 2019:69351472019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Boag SE, Andreano E and Spyridopoulos I:
Lymphocyte communication in myocardial ischemia/reperfusion injury.
Antioxid Redox Signal. 26:660–675. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hamacher-Brady A, Brady NR and Gottlieb
RA: The interplay between pro-death and pro-survival signaling
pathways in myocardial ischemia/reperfusion injury: Apoptosis meets
autophagy. Cardiovasc Drugs Ther. 20:445–462. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Niemann B, Schwarzer M and Rohrbach S:
Heart and mitochondria: Pathophysiology and implications for
cardiac surgeons. Thorac Cardiovasc Surg. 66:11–19. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sanchez-Hernandez CD, Torres-Alarcon LA,
Gonzalez-Cortes A and Peon AN: Ischemia/reperfusion injury:
Pathophysiology, current clinical management, and potential
preventive approaches. Mediators Inflamm. 2020:84053702020.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ong SB, Katwadi K, Kwek XY, Ismail NI,
Chinda K, Ong SG and Hausenloy DJ: Non-coding RNAs as therapeutic
targets for preventing myocardial ischemia-reperfusion injury.
Expert Opin Ther Targets. 22:247–261. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu H, Wu J, Li D, Zhou J, Yu H and Ma L:
Knockdown of lncRNA MALAT1 attenuates acute myocardial infarction
through miR-320-Pten axis. Biomed Pharmacother. 106:738–746. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liang H, Su X, Wu Q, Shan H, Lv L, Yu T,
Zhao X, Sun J, Yang R, Zhang L, et al: LncRNA 2810403D21Rik/Mirf
promotes ischemic myocardial injury by regulating autophagy through
targeting Mir26a. Autophagy. 16:1077–1091. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu Z, Zhao S, Li C and Liu C: LncRNA TUG1
serves an important role in hypoxia-induced myocardial cell injury
by regulating the miR1455pBinp3 axis. Mol Med Rep. 17:2422–2430.
2018.PubMed/NCBI
|
|
14
|
Yu SY, Dong B, Zhou SH and Tang L: LncRNA
UCA1 modulates cardiomyocyte apoptosis by targeting miR-143 in
myocardial ischemia-reperfusion injury. Int J Cardiol. 247:312017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao ZH, Hao W, Meng QT, Du XB, Lei SQ and
Xia ZY: Long non-coding RNA MALAT1 functions as a mediator in
cardioprotective effects of fentanyl in myocardial
ischemia-reperfusion injury. Cell Biol Int. 41:62–70. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xue X and Luo L: LncRNA HIF1A-AS1
contributes to ventricular remodeling after myocardial
ischemia/reperfusion injury by adsorption of microRNA-204 to
regulating SOCS2 expression. Cell Cycle. 18:2465–2480. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiong W, Qu Y, Chen H and Qian J: Insight
into long noncoding RNA-miRNA-mRNA axes in myocardial
ischemia-reperfusion injury: The implications for mechanism and
therapy. Epigenomics. 11:1733–1748. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang Z, Ye B, Wang Z, Han J, Lin L, Shan
P, Cai X and Huang W: Inhibition of LncRNA-HRIM increases cell
viability by regulating autophagy levels during
hypoxia/reoxygenation in myocytes. Cell Physiol Biochem.
46:1341–1351. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu ST, Chang YL, Wang WM, Chung MH, Lin
WS, Chou WY and Huang SM: A non-covalent interaction between small
ubiquitin-like modifier-1 and Zac1 regulates Zac1 cellular
functions. Int J Biochem Cell Biol. 44:547–555. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nakayama T: Genetic polymorphisms of
prostacyclin synthase gene and cardiovascular disease. Int Angiol.
29((2 Suppl)): S33–S42. 2010.
|
|
21
|
Birkenkamp-Demtroder K, Hahn SA, Mansilla
F, Thorsen K, Maghnouj A, Christensen R, Øster B and Ørntoft TF:
Keratin23 (KRT23) knockdown decreases proliferation and affects the
DNA damage response of colon cancer cells. PLoS One. 8:e735932013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Turkieh A, Charrier H, Dubois-Deruy E,
Porouchani S, Bouvet M and Pinet F: Noncoding RNAs in cardiac
autophagy following myocardial infarction. Oxid Med Cell Longev.
2019:84386502019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hayden MS and Ghosh S: NF-κB, the first
quarter-century: Remarkable progress and outstanding questions.
Genes Dev. 26:203–234. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hall G, Hasday JD and Rogers TB:
Regulating the regulator: NF-kappaB signaling in heart. J Mol Cell
Cardiol. 41:580–591. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Oeckinghaus A and Ghosh S: The NF-kappaB
family of transcription factors and its regulation. Cold Spring
Harb Perspect Boil. 1:a0000342009.
|
|
26
|
Thomas-Jardin SE, Dahl H, Nawas AF,
Bautista M and Delk NA: NF-κB signaling promotes
castration-resistant prostate cancer initiation and progression.
Pharmacol Ther. 211:1075382020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang M, Yan S and Zhou Y:
Trans-cinnamaldehyde reverses depressive-like behaviors in chronic
unpredictable mild stress rats by inhibiting NF-κB/NLRP3
inflammasome pathway. Evid Based Complement Alternat Med.
2020:45721852020.PubMed/NCBI
|
|
28
|
Li Q and Verma IM: NF-kappaB regulation in
the immune system. Nat Rev Immunol. 2:725–734. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Abd El-Mohsen M, Bayele H, Kuhnle G,
Gibson G, Debnam E, Kaila Srai S, Rice-Evans C and Spencer JP:
Distribution of [3H]trans-resveratrol in rat tissues following oral
administration. Br J Nutr. 96:62–70. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liang X, Huang J, Lin X, Qin F, Wen Q,
Chen C, Li Y, Ge W and Huang R: The effect of
17-methoxyl-7-hydroxy-benzene-furanchalcone on NF-κB and the
inflammatory response during myocardial ischemia reperfusion injury
in rats. J Cardiovasc Pharmacol. 63:68–75. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu L, Wei P, Cao Y, Zhang Q, Liu M, Liu
XD, Wang ZL and Zhang PY: Effect of total peony glucoside
pretreatment on NF-κB and ICAM-1 expression in myocardial tissue of
rat with myocardial ischemia-reperfusion injury. Genet Mol Res.
15:2016. View Article : Google Scholar
|
|
32
|
Chang HY, Chen YC, Lin JG, Lin IH, Huang
HF, Yeh CC, Chen JJ and Huang GJ: Asatone prevents acute lung
injury by reducing expressions of NF-[Formula: See text]B, MAPK and
inflammatory cytokines. Am J Chin Med. 46:651–671. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang Y, Duan W, Jin Z, Yi W, Yan J, Zhang
S, Wang N, Liang Z, Li Y, Chen W, et al: JAK2/STAT3 activation by
melatonin attenuates the mitochondrial oxidative damage induced by
myocardial ischemia/reperfusion injury. J Pineal Res. 55:275–286.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen J, Hu Q, Zhang BF, Liu XP, Yang S and
Jiang H: Long noncoding RNA UCA1 inhibits ischaemia/reperfusion
injury induced cardiomyocytes apoptosis via suppression of
endoplasmic reticulum stress. Genes Genomics. 41:803–810. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang K, Liu F, Liu CY, An T, Zhang J, Zhou
LY, Wang M, Dong YH, Li N, Gao JN, et al: The long noncoding RNA
NRF regulates programmed necrosis and myocardial injury during
ischemia and reperfusion by targeting miR-873. Cell Death Differ.
23:1394–1405. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zheng C, Wu Z, Tian L, Li D, Wang X, He Y,
He Y, Jin W, Li M, Zhu Q, et al: Long noncoding RNA AK12348 is
involved in the regulation of myocardial ischaemia-reperfusion
injury by targeting PARP and caspase-3. Heart Lung Circ.
27:e51–e58. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Luo M, Sun Q, Zhao H, Tao J and Yan D:
Long noncoding RNA NEAT1 sponges miR-495-3p to enhance myocardial
ischemia-reperfusion injury via MAPK6 activation. J Cell Physiol.
235:105–113. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang F, Qin Y, Wang Y, Li A, Lv J, Sun X,
Che H, Han T, Meng S, Bai Y and Wang L: LncRNA KCNQ1OT1 mediates
pyroptosis in diabetic cardiomyopathy. Cell Physiol Biochem.
50:1230–1244. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xie XJ, Fan DM, Xi K, Chen YW, Qi PW, Li
QH, Fang L and Ma LG: Suppression of microRNA-135b-5p protects
against myocardial ischemia/reperfusion injury by activating
JAK2/STAT3 signaling pathway in mice during sevoflurane anesthesia.
Biosci Rep. 37:BSR201701862017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hu X, Dai S, Wu WJ, Tan W, Zhu X, Mu J,
Guo Y, Bolli R and Rokosh G: Stromal cell derived factor-1 alpha
confers protection against myocardial ischemia/reperfusion injury:
Role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis.
Circulation. 116:654–663. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang W, Li Y and Wang P: Long non-coding
RNA-ROR aggravates myocardial ischemia/reperfusion injury. Braz J
Med Biol Res. 51:e65552018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hausenloy DJ and Yellon DM: Myocardial
ischemia-reperfusion injury: A neglected therapeutic target. J Clin
Invest. 123:92–100. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shin IW, Jang IS, Lee SM, Park KE, Ok SH,
Sohn JT, Lee HK and Chung YK: Myocardial protective effect by
ulinastatin via an anti-inflammatory response after regional
ischemia/reperfusion injury in an in vivo rat heart model. Korean J
Anesthesiol. 61:499–505. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hadi NR, Alamran F, Yousif M and Zamil ST:
Antiapoptotic effect of simvastatin ameliorates myocardial
ischemia/reperfusion injury. ISRN Pharmacol. 2013:8150942013.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hu X, Cui B, Zhou X, Xu C, Lu Z and Jiang
H: Ethyl pyruvate reduces myocardial ischemia and reperfusion
injury by inhibiting high mobility group box 1 protein in rats. Mol
Biol Rep. 39:227–231. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
He XH, Wang Y, Yan XT, Wang YL, Wang CY,
Zhang ZZ, Li H and Jiang HX: Transduction of PEP-1-heme oxygenase-1
fusion protein reduces myocardial ischemia/reperfusion injury in
rats. J Cardiovasc Pharmacol. 62:436–442. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Xu Q, Deng F, Xing Z, Wu Z, Cen B, Xu S,
Zhao Z, Nepomuceno R, Bhuiyan MIH, Sun D, et al: Long non-coding
RNA C2dat1 regulates CaMKIIdelta expression to promote neuronal
survival through the NF-κB signaling pathway following cerebral
ischemia. Cell Death Dis. 7:e21732016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wu M, Gu J, Mei S, Xu D, Jing Y, Yao Q,
Chen M, Yang M, Chen S, Yang B, et al: Resveratrol delays
polycystic kidney disease progression through attenuation of
nuclear factor κB-induced inflammation. Nephrol Dial Transplant.
31:1826–1834. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Tian F, Zang WD, Hou WH, Liu HT and Xue
LX: Nuclear factor-kB signaling pathway constitutively activated in
esophageal squamous cell carcinoma cell lines and inhibition of
growth of cells by small interfering RNA. Acta Biochim Biophys Sin
(Shanghai). 38:318–326. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Krappmann D and Vincendeau M: Mechanisms
of NF-κB deregulation in lymphoid malignancies. Semin Cancer Biol.
39:3–14. 2016. View Article : Google Scholar : PubMed/NCBI
|
